<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Caring Brands, Inc. Common Stock — News on 6ix</title>
<link>https://6ix.com/company/caring-brands-inc-common-stock</link>
<description>Latest news and press releases for Caring Brands, Inc. Common Stock on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 03 Feb 2026 13:25:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/caring-brands-inc-common-stock" rel="self" type="application/rss+xml" />
<item>
<title>Caring Brands Secures Two New U.S. Patents Strengthening Hair Enzyme Booster Technology</title>
<link>https://6ix.com/company/caring-brands-inc-common-stock/news/caring-brands-secures-two-u-132500845</link>
<guid isPermaLink="true">https://6ix.com/company/caring-brands-inc-common-stock/news/caring-brands-secures-two-u-132500845</guid>
<pubDate>Tue, 03 Feb 2026 13:25:00 GMT</pubDate>
<description>Fort Pierce, FL, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (Nasdaq: CABR) today announced the issuance of two new United States patents covering proprietary methods and compositions designed to enhance enzymatic activity in hair follicles, further strengthening the Company’s intellectual property portfolio supporting its Hair Enzyme Booster product. The newly issued patents, granted by the United States Patent and Trademark Office in January 2026, relate to technologies that increase</description>
</item>
<item>
<title>Caring Brands Announces Exclusive Global License to Manufacture and Market Emesyl</title>
<link>https://6ix.com/company/caring-brands-inc-common-stock/news/caring-brands-announces-exclusive-global-133000501</link>
<guid isPermaLink="true">https://6ix.com/company/caring-brands-inc-common-stock/news/caring-brands-announces-exclusive-global-133000501</guid>
<pubDate>Mon, 05 Jan 2026 13:30:00 GMT</pubDate>
<description>Jupiter, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (Nasdaq: CABR) today announced that it has entered into an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and distribute Emesyl, Itonis’s over-the-counter (OTC) nausea relief product. The agreement provides Caring Brands with full rights to commercialize Emesyl and to oversee all manufacturing activities associated with the product. Under the terms of the agreement, Caring Brands will assume respo</description>
</item>
<item>
<title>Caring Brands Announces Closing of $4,000,000 Million Uplisting to Nasdaq</title>
<link>https://6ix.com/company/caring-brands-inc-common-stock/news/caring-brands-announces-closing-4-220000378</link>
<guid isPermaLink="true">https://6ix.com/company/caring-brands-inc-common-stock/news/caring-brands-announces-closing-4-220000378</guid>
<pubDate>Fri, 14 Nov 2025 22:00:00 GMT</pubDate>
<description>FORT PIERCE, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. (“Caring Brands” or the “Company”), a wellness consumer products company offering several over-the-counter (OTC) and cosmetic consumer products, today announced the closing of its underwritten U.S. public offering of 1,000,000 shares of common stock at a public offering price of $4.00 per share for aggregate gross proceeds of approximately US $4,000,000, prior to deducting underwriting discounts and offering expenses (the “</description>
</item>
<item>
<title>Caring Brands Announces Pricing of $4,000,000 Million Uplisting to Nasdaq</title>
<link>https://6ix.com/company/caring-brands-inc-common-stock/news/caring-brands-announces-pricing-4-005800362</link>
<guid isPermaLink="true">https://6ix.com/company/caring-brands-inc-common-stock/news/caring-brands-announces-pricing-4-005800362</guid>
<pubDate>Thu, 13 Nov 2025 00:58:00 GMT</pubDate>
<description>FORT PIERCE, Fla., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. (“Caring Brands” or the “Company”), a wellness consumer products company offering several over-the-counter (OTC) and cosmetic consumer products, today announced the pricing of its underwritten U.S. public offering of 1,000,000 common shares at a public offering price of $4.00 per common share for aggregate gross proceeds of approximately US $4,000,000, prior to deducting underwriting discounts and offering expenses (the “Of</description>
</item>
</channel>
</rss>